Clearline Capital’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3M | Buy |
+1,326,259
| New | +$3M | 0.11% | 76 |
|
|
2023
Q1 | – | Sell |
-27,156
| Closed | -$66.5K | – | 109 |
|
|
2022
Q4 | $66.5K | Sell |
27,156
-92,938
| -77% | -$228K | 0.01% | 119 |
|
|
2022
Q3 | $396K | Hold |
120,094
| – | – | 0.05% | 119 |
|
|
2022
Q2 | $586K | Hold |
120,094
| – | – | 0.08% | 105 |
|
|
2022
Q1 | $909K | Sell |
120,094
-1,918
| -2% | -$14.5K | 0.1% | 92 |
|
|
2021
Q4 | $949K | Hold |
122,012
| – | – | 0.1% | 94 |
|
|
2021
Q3 | $1.04M | Buy |
122,012
+200
| +0.2% | +$1.7K | 0.1% | 98 |
|
|
2021
Q2 | $1.09M | Buy |
+121,812
| New | +$1.09M | 0.16% | 86 |
|